抗甲状腺抗体对反复流产的影响:元分析
Hongyan Song1,2, Tianwei Cui1, Shaoqi Shi1
1Department of Reproductive Medicine, First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
The journal of obstetrics and gynaecology research
|April 14, 2024
概括
具有抗甲状腺过氧化酶 (抗TPO) 和抗甲状腺球蛋白 (抗TG) 抗体的女性面临更高的反复流产 (RM) 风险. 这一元分析证实了这些抗体与RM患病率之间的显著关联.
科学领域:
- 生殖免疫学 生殖免疫学
- 内分泌学 在内分泌学.
背景情况:
- 经常性流产 (RM) 影响了大量女性,而抗甲状腺抗体的作用仍在争论中.
- 之前的研究已经探索了抗甲状腺抗体和RM之间的关联,需要进行全面的分析.
结论:
- 与抗体阴性女性相比,具有抗TPO和/或抗TG抗体的女性表现出较高的RM风险.
- 需要进一步的研究来阐明抗甲状腺抗体在RM中的确切作用以及治疗的潜在益处.
- 局限性包括检测方法的变化,其他孕产妇免疫系统疾病的潜在混,以及缺乏关于甲状腺素治疗影响的数据.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
136
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
136


